TCI Wealth Advisors’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

TCI Wealth Advisors’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-273	Closed	-$2K	–	1438
2016 Q2	$2K	Hold	273	–	–	﹤0.01%	996
2016 Q1	$2K	Buy	+273	New	+$2.01K	﹤0.01%	1009

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

TCI Wealth Advisors's JNP Position: Q3 2016 in Review

TCI Wealth Advisors sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2016, closing a stake of 273 shares — an estimated $2K sold.

TCI Wealth Advisors first reported a position in JNP in Q1 2016 and held it in 2 quarters. The position peaked at $2K in Q2 2016. 46 funds tracked by Wall St. Rank hold JNP as of Q3 2016.

TCI Wealth Advisors reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
TCI Wealth Advisors sold 273 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2016, an estimated $2K.
TCI Wealth Advisors first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2016 and held it in 2 quarters.
TCI Wealth Advisors's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q2 2016.
46 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2016.

Based on TCI Wealth Advisors's 13F filing for Q3 2016, filed 1 Nov 2016.